Infusion therapy market to reach $26.7 billion by 2020

NEW YORK – Persistence Market Research has  published a new market report titled “Global Market Study on Home Infusion Therapy: Needleless Connectors to Witness Highest Growth by 2020.” The global home infusion therapy market is estimated at USD 15.9 billion in 2014, and is expected to reach USD 26.7 billion by 2020, growing at a CAGR of 9.0% from 2014 to 2020.

The study identifies key growth factors as: rising aging population, increasing number of chronic diseases, expanding home care market for infusion therapy, technology advancement in infusion devices and increasing application of infusion devices in pain relieving. Increase in the use of ambulatory infusion pumps, increasing number of mergers and acquisitions and rising number of product innovations are some of the key market trends.

North America has the largest market for home infusion therapy, followed by Europe. Some of the other fast-growing markets for home infusion therapy are Japan, China, Germany and the US.

Baxter is one of the leading players in the home infusion therapy market. Other major players in the market include B. Braun Melsungen AG, Fresenius Kabi AG and CareFusion Corporation.

Global Market Study on Home Infusion Therapy: Needleless Connectors to Witness Highest Growth by 2020 covers global home infusion therapy market by device types, application, diseases and geography. By device type, the study covers infusion pump, intravenous set, needleless connectors. By application, the study covers anti-infectives, enteral nutrition, specialty pharmaceuticals, pain management, chemotherapy, hydration infusion pump. By disease type, the study covers diabetes and cancer.